From The Cancer Genome Atlas (TCGA) database, we found that FOXD2-AS1 was significantly increased in bladder cancer according to analysis of 19 pairs of cancer and adjacent noncancerous samples (Fig. 1a). This evidence concerns the gene FOXD2 and urinary bladder cancer.